CAR-T Treatment in China for International Patients

China has become an important part of the global CAR-T landscape, and international patients increasingly investigate treatment or clinical options there. But the existence of a CAR-T program does not mean a particular patient is eligible for it.

The first step should be a case review, not a plane ticket.

A CAR-T inquiry commonly needs:

• Confirmed diagnosis and disease subtype
• Prior lines of therapy
• Pathology and molecular information where relevant
• Recent imaging and laboratory results
• Current disease status
• Organ-function and general clinical information
• A complete treatment timeline

The treating hospital determines clinical eligibility, treatment selection and medical risk.

Golden Age Care does not sell CAR-T products, provide medical advice or promise acceptance.

We help international patients organize the case and determine whether a credible China route exists before major travel and financial commitments are made.

If a route proceeds, the work can extend into records, hospital communication, arrival planning, treatment-period coordination and a usable handoff home.